Treatment Modalities for Conjunctival Melanoma

被引:7
作者
Krause, L. [1 ]
Mladenova, A. [2 ]
Bechrakis, N. E. [3 ]
Kreusel, K-M. [4 ]
Plath, T.
Moser, L. [5 ]
Foerster, M. [2 ]
机构
[1] Stad Klinikum Dessau, Augenklin, D-06847 Dessau, Germany
[2] Charite Univ Med Berlin, Augenklin, Berlin, Germany
[3] Univ Augenklin Innsbruck, Innsbruck, Austria
[4] DRK Kliniken Berlin Westend, Augen Zentrum, Berlin, Germany
[5] Charite Univ Med Berlin, Klin Radioonkol & Strahlentherapie, Berlin, Germany
关键词
conjunctival melanoma; strontium; brachytherapy; tumour excision; recurrence rate; PRIMARY ACQUIRED MELANOSIS; MALIGNANT-MELANOMA; MITOMYCIN-C; FOLLOW-UP; CHEMOTHERAPY; RADIOTHERAPY; RECURRENCE; EXCISION; THERAPY; POPULATION;
D O I
10.1055/s-0028-1109651
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Because of high local recurrence rates after excision of conjunctival melanoma adjuvant local chemotherapy employing mitomycin C (MMC) or irradiation is recommended. Brachytherapy is possible with ruthenium-106-plaques ((106)Ru) or with the strontium-90-plaques ((90)Sr). Patients and Methods: Fifty-six patients received an excision and adjuvant radiotherapy of conjunctival melanoma between 1992 and 2007. The mean follow-up was 42 months (12-151 months). Mean age was 62 (28-86) years. As an adjuvant radiotherapy 15 patients received X-ray irradiation, 12 patients received (106)Ru-brachytherapy, 4 patients received proton beam therapy and 16 patients with conjunctival melanoma were treated with adjuvant strontium-90 brachytherapy after tumour excision. Four patients received proton beam irradiation and in 13 patients an exenteratio was performed. Results: Twelve patients (21%) developed tumour recurrences in or adjacent to the irradiated area. Thirteen patients (22%) showed a recurrence distant from the primary site. Ten patients (18%) developed systemic metastasis during follow-up. Seven patients (46%) had no recurrence during the follow-up. Three patients (20%) had a recurrence in the treated or adjacent areas. Eight patients (53%) developed new tumours in non-treated areas. Conclusions: Adjuvant radiotherapy allows an acceptable local tumour control rate after excision of conjunctival melanoma. No obvious differences regarding tumour control or systemic metastasis could be seen between the different modes of radiotherapy used.
引用
收藏
页码:1012 / 1016
页数:5
相关论文
共 30 条
  • [1] Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study
    Anastassiou, G
    Heiligenhaus, A
    Bechrakis, N
    Bader, E
    Bornfeld, N
    Steuhl, KP
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (02) : 163 - 167
  • [2] BUCKMAN G, 1988, OPHTHALMOLOGY, V95, P1053
  • [3] Demirci H, 2000, ARCH OPHTHALMOL-CHIC, V118, P885
  • [4] CLINICAL PREDICTIVE FACTORS FOR DEVELOPMENT OF RECURRENCE AND METASTASIS IN CONJUNCTIVAL MELANOMA - A REVIEW OF 68 CASES
    DEPOTTER, P
    SHIELDS, CL
    SHIELDS, JA
    MENDUKE, H
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (10) : 624 - 630
  • [5] TOPICAL CHEMOTHERAPY FOR CONJUNCTIVAL MELANOMA
    FINGER, PT
    MILNER, MS
    MCCORMICK, SA
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (11) : 751 - 753
  • [6] Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia
    Finger, PT
    Czechonska, G
    Liarikos, S
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (05) : 476 - 479
  • [7] JAKOBIEC FA, 1988, OPHTHALMOLOGY, V95, P1058
  • [8] Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia
    Khong, J. J.
    Muecke, J.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (07) : 819 - 822
  • [9] Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma
    Krause, L.
    Ritter, C.
    Wachtlin, J.
    Kreusel, K. -M.
    Hoecht, S.
    Foerster, M. H.
    Bechrakis, N. E.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (07) : 649 - 652
  • [10] LOMMATZSCH P, 1964, Klin Monbl Augenheilkd, V144, P856